Therapeutic Drug Monitoring in Oncology: International Association of Therapeutic Drug Monitoring and Clinical Toxicology Recommendations for 5‐Fluorouracil Therapy
Jan H. Beumer(Johns Hopkins University), Markus Joerger(Kantonsspital St. Gallen), Robert B. Diasio(Mayo Clinic), Carmen J. Allegra(National Cancer Institute), Ron H.J. Mathijssen(Erasmus MC), Yusuke Tanigawara(Keio University), Edward Chu(Albert Einstein College of Medicine), G. Milano(Centre Antoine Lacassagne), Li Zhang(Fourth Hospital of Changsha), Tae Won Kim(Asan Medical Center), Narikazu Boku(Tokyo Medical University), Katsuki Muneoka(Nagara Medical Center), Dirk Arnold(Asklepios Klinik Altona)
Cited by 126
Related Papers
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer
|International Journal of Clinical Oncology|2017|2.5k
Maintenance Olaparib for Germline <i>BRCA</i> -Mutated Metastatic Pancreatic Cancer
|New England Journal of Medicine|2019|2.2k
Localised colon cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2020|1.3k
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2018|1.1k